Follow the money: The antidote economy
The antidote for an opioid overdose costs a few dollars. So why doesn't it always reach the person on the floor? We're following the money through America's antidote economy.
**This episode of Business Daily begins with a real call to 911**
There is an antidote for an opioid overdose. It costs a few dollars. The nasal spray technology means it can be administered without needles and can restart a person's breathing within minutes. So why doesn't it always reach the person on the floor? We following the money through the antidote economy. A life-saving drug that costs pennies to make sold over the counter for $52. But when drug companies were sued for their role in America's opioid crisis, some pharmaceutical companies' settlements included paying out using antidote kits valued at $125. Who profits, who pays, and what determines whether an overdose kit is ever in the room when it is needed?
Presenter: Sam Fenwick
Producers: Josh Martin and Matt Lines
(Photo: Two naloxone nasal spray medications used for opioid overdose sit on a brown table on 11 September 2024. Credit: Peg Alexander/Ä¢¹½¶ÌÊÓÆµ Images)
You can email the team: businessdaily@bbc.co.uk
Last on
Featured
-
.
Broadcasts
- Tue 28 Jul 2026 07:32GMTÄ¢¹½¶ÌÊÓÆµ World Service
- Tue 28 Jul 2026 14:32GMTÄ¢¹½¶ÌÊÓÆµ World Service
Podcast
-
Business Daily
The daily drama of money and work from the Ä¢¹½¶ÌÊÓÆµ.